Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

SLANG Worldwide

CNSX:SLNG
Snowflake Description

High growth potential and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SLNG
CNSX
CA$81M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. The last earnings update was 95 days ago. More info.


Add to Portfolio Compare Print
  • SLANG Worldwide has significant price volatility in the past 3 months.
SLNG Share Price and Events
7 Day Returns
-9.5%
CNSX:SLNG
-13.8%
CA Pharmaceuticals
-6.2%
CA Market
1 Year Returns
-87.7%
CNSX:SLNG
-65.6%
CA Pharmaceuticals
-2%
CA Market
SLNG Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
SLANG Worldwide (SLNG) -9.5% -23% -39.4% -87.7% - -
CA Pharmaceuticals -13.8% -22.6% -20.7% -65.6% 0.8% 283%
CA Market -6.2% -5% -2.8% -2% 0.6% 8.9%
1 Year Return vs Industry and Market
  • SLNG underperformed the Pharmaceuticals industry which returned -65.6% over the past year.
  • SLNG underperformed the Market in Canada which returned -2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

SLNG Value

 Is SLANG Worldwide undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for SLANG Worldwide. This is due to cash flow or dividend data being unavailable. The share price is CA$0.285.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for SLANG Worldwide's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are SLANG Worldwide's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:SLNG PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$0.02
CNSX:SLNG Share Price ** CNSX (2020-02-28) in CAD CA$0.29
Canada Pharmaceuticals Industry PE Ratio Median Figure of 11 Publicly-Listed Pharmaceuticals Companies 14.69x
Canada Market PE Ratio Median Figure of 509 Publicly-Listed Companies 14.76x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of SLANG Worldwide.

CNSX:SLNG PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:SLNG Share Price ÷ EPS (both in CAD)

= 0.29 ÷ 0.02

16.6x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SLANG Worldwide is overvalued based on earnings compared to the CA Pharmaceuticals industry average.
  • SLANG Worldwide is overvalued based on earnings compared to the Canada market.
Price based on expected Growth
Does SLANG Worldwide's expected growth come at a high price?
Raw Data
CNSX:SLNG PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 16.6x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
111.4%per year
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 6 Publicly-Listed Pharmaceuticals Companies 1.38x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

CNSX:SLNG PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 16.6x ÷ 111.4%

0.15x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SLANG Worldwide is good value based on expected growth next year.
Price based on value of assets
What value do investors place on SLANG Worldwide's assets?
Raw Data
CNSX:SLNG PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.92
CNSX:SLNG Share Price * CNSX (2020-02-28) in CAD CA$0.29
Canada Pharmaceuticals Industry PB Ratio Median Figure of 154 Publicly-Listed Pharmaceuticals Companies 1.28x
Canada Market PB Ratio Median Figure of 2,345 Publicly-Listed Companies 1.31x
CNSX:SLNG PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:SLNG Share Price ÷ Book Value per Share (both in CAD)

= 0.29 ÷ 0.92

0.31x

* Primary Listing of SLANG Worldwide.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SLANG Worldwide is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess SLANG Worldwide's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. SLANG Worldwide has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SLNG Future Performance

 How is SLANG Worldwide expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
111.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is SLANG Worldwide expected to grow at an attractive rate?
  • SLANG Worldwide's earnings growth is expected to exceed the low risk savings rate of 1.4%.
Growth vs Market Checks
  • SLANG Worldwide's earnings growth is expected to exceed the Canada market average.
  • SLANG Worldwide's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:SLNG Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:SLNG Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 111.4%
CNSX:SLNG Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 79.9%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 69.4%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 39.9%
Canada Market Earnings Growth Rate Market Cap Weighted Average 9.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 4.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:SLNG Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:SLNG Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 203 19 2
2020-12-31 187 6 3
2020-02-29
2019-12-31 33 -7 2
CNSX:SLNG Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 22 -17 3
2019-06-30 15 -12 -13
2019-03-31 9 -13 -44
2018-12-31 5 -3 -28
2018-09-30 3 -3 -31
2017-12-31 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • SLANG Worldwide's earnings are expected to grow significantly at over 20% yearly.
  • SLANG Worldwide's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:SLNG Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from SLANG Worldwide Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:SLNG Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 0.08 0.08 0.08 1.00
2020-12-31 0.01 0.07 -0.05 2.00
2020-02-29
2019-12-31 -0.02 0.00 -0.03 2.00
CNSX:SLNG Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 0.02
2019-06-30 -0.09
2019-03-31 -0.39
2018-12-31 -0.37
2018-09-30 -0.47
2017-12-31 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if SLANG Worldwide will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess SLANG Worldwide's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
SLANG Worldwide has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SLNG Past Performance

  How has SLANG Worldwide performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare SLANG Worldwide's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient data to establish if SLANG Worldwide's year on year earnings growth rate was positive over the past 5 years.
  • SLANG Worldwide has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • SLANG Worldwide has become profitable in the last year making it difficult to compare the CA Pharmaceuticals industry average.
Earnings and Revenue History
SLANG Worldwide's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from SLANG Worldwide Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:SLNG Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 22.06 3.27 25.56
2019-06-30 15.21 -13.11 28.11
2019-03-31 8.67 -43.81 22.79
2018-12-31 4.77 -28.28 17.10
2018-09-30 2.60 -30.91 15.42
2017-12-31 0.07 -1.46 0.31

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • SLANG Worldwide has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • It is difficult to establish if SLANG Worldwide has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if SLANG Worldwide improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess SLANG Worldwide's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
SLANG Worldwide has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SLNG Health

 How is SLANG Worldwide's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up SLANG Worldwide's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • SLANG Worldwide is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • SLANG Worldwide's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of SLANG Worldwide's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 6.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from SLANG Worldwide Company Filings, last reported 4 months ago.

CNSX:SLNG Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 222.38 4.11 9.70
2019-06-30 217.76 4.23 13.03
2019-03-31 188.51 4.45 13.07
2018-12-31 65.60 2.75 0.18
2018-09-30 64.28 2.63 3.16
2017-12-31 0.94 0.00 0.17
  • SLANG Worldwide's level of debt (1.8%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if SLANG Worldwide's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on SLANG Worldwide's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess SLANG Worldwide's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. SLANG Worldwide has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SLNG Dividends

 What is SLANG Worldwide's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from SLANG Worldwide dividends.
If you bought CA$2,000 of SLANG Worldwide shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate SLANG Worldwide's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate SLANG Worldwide's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:SLNG Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 2.9%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.7%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:SLNG Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2020-02-29
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as SLANG Worldwide has not reported any payouts.
  • Unable to verify if SLANG Worldwide's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of SLANG Worldwide's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as SLANG Worldwide has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess SLANG Worldwide's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can SLANG Worldwide afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. SLANG Worldwide has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SLNG Management

 What is the CEO of SLANG Worldwide's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Peter W. Miller
COMPENSATION CA$150,000
TENURE AS CEO 2.8 years
CEO Bio

Mr. Peter W. J. Miller has been Chief Executive Officer at SLANG Worldwide Inc. since May 2017. Mr. Miller serves as Chairman at SLANG Worldwide Inc. and has been its Director since 2017. He served as Chief Executive Officer and Director at Fire Cannabis Inc. Mr. Miller served as the President of Agripharm Corp at Mettrum Health Corp.

CEO Compensation
  • Peter W.'s compensation has increased in line with SLANG Worldwide recently becoming profitable.
  • Peter W.'s remuneration is about average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the SLANG Worldwide management team in years:

1.8
Average Tenure
  • The average tenure for the SLANG Worldwide management team is less than 2 years, this suggests a new team.
Management Team

Peter W. Miller

TITLE
Chairman & CEO
COMPENSATION
CA$150K
TENURE
2.8 yrs

Billy Levy

TITLE
President & Director
COMPENSATION
CA$155K

Kelly Ehler

TITLE
Chief Financial Officer
COMPENSATION
CA$466K
AGE
57
TENURE
1.8 yrs

Kristina McCahon

TITLE
Director of Investor Relations & Chief of Staff
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the SLANG Worldwide board of directors in years:

2.2
Average Tenure
57
Average Age
  • The average tenure for the SLANG Worldwide board of directors is less than 3 years, this suggests a new board.
Board of Directors

Billy Levy

TITLE
President & Director
COMPENSATION
CA$155K

Keith Stein

TITLE
Independent Director
AGE
55
TENURE
3.1 yrs

Peter W. Miller

TITLE
Chairman & CEO
COMPENSATION
CA$150K

William Stocks

TITLE
Independent Director
AGE
65
TENURE
1.3 yrs

Chris Driessen

TITLE
Director
TENURE
3.1 yrs

Colin Baden

TITLE
Director
AGE
57
TENURE
1.3 yrs

Olaf van Tulder

TITLE
Independent Director
TENURE
3.1 yrs

Chris McElvany

TITLE
Director
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • SLANG Worldwide individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
25. Feb 20 Sell Christopher Driessen Individual 24. Feb 20 25. Feb 20 -165,000 CA$0.31 CA$-48,561
21. Feb 20 Sell Christopher Driessen Individual 19. Feb 20 21. Feb 20 -145,000 CA$0.32 CA$-45,638
23. Sep 19 Buy Christopher Driessen Individual 08. Apr 19 08. Apr 19 200,000 CA$0.75 CA$149,259
X
Management checks
We assess SLANG Worldwide's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. SLANG Worldwide has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SLNG News

Simply Wall St News

Do Directors Own SLANG Worldwide Inc. (CNSX:SLNG) Shares?

Check out our latest analysis for SLANG Worldwide CNSX:SLNG Ownership Summary, July 11th 2019 What Does The Lack Of Institutional Ownership Tell Us About SLANG Worldwide? … Insider Ownership Of SLANG Worldwide The definition of an insider can differ slightly between different countries, but members of the board of directors always count. … General Public Ownership The general public, who are mostly retail investors, collectively hold 77% of SLANG Worldwide shares.

Simply Wall St -

SLNG Company Info

Description

SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. The company develops, markets, and distributes a portfolio of branded cannabis products across 2,600 stores in the United States. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 26, 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.

Details
Name: SLANG Worldwide Inc.
SLNG
Exchange: CNSX
Founded: 2017
CA$80,935,980
283,985,896
Website: http://www.slangworldwide.co
Address: SLANG Worldwide Inc.
50 Carroll Street,
Toronto,
Ontario, M4M 3G3,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX SLNG Common Shares Canadian National Stock Exchange CA CAD 29. Jan 2019
OTCPK SLGW.F Common Shares Pink Sheets LLC US USD 29. Jan 2019
DB 84S Common Shares Deutsche Boerse AG DE EUR 29. Jan 2019
Number of employees
Current staff
Staff numbers
0
SLANG Worldwide employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/29 02:00
End of day share price update: 2020/02/28 00:00
Last estimates confirmation: 2020/01/08
Last earnings filing: 2019/11/26
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.